Myanmar vs Syrian Arab Republic: Confirmed cases of MDR-TB started treatment for MDR-TB
Myanmar
57.0%
in 2012
Syrian Arab Republic
54.0%
in 2012
Myanmar rank
43rd
Syrian Arab Republic rank
45th
Confirmed cases of MDR-TB started treatment for MDR-TB over time
- Myanmar
- Syrian Arab Republic
How they compare
Myanmar currently reports 57.0% against 54.0% in Syrian Arab Republic, a difference of 3.0%.
That makes Myanmar's figure about 1.1 times Syrian Arab Republic's.
The two have swapped places 3 times across 5 shared years of data; in 2008 it was Syrian Arab Republic ahead.
Myanmar ranks 43rd and Syrian Arab Republic ranks 45th of 54 countries.
Across the 2 decades both report, Myanmar averaged higher in 1 and Syrian Arab Republic in 1.
Head to head by decade
| Decade | Myanmar | Syrian Arab Republic | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 4.0% | 90.5% | 86.5% | Syrian Arab Republic |
| 2010s | 60.3% | 52.0% | 8.3% | Myanmar |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher confirmed cases of mdr-tb started treatment for mdr-tb, Myanmar or Syrian Arab Republic?
- Myanmar, at 57.0% against 54.0% in Syrian Arab Republic as of 2012.
- What is the difference in confirmed cases of mdr-tb started treatment for mdr-tb between Myanmar and Syrian Arab Republic?
- 3.0%, with Myanmar ahead.
- How many years of comparable data are there for Myanmar and Syrian Arab Republic?
- 5 years are reported by both, from 2008 to 2012.
- How do Myanmar and Syrian Arab Republic rank globally for confirmed cases of mdr-tb started treatment for mdr-tb?
- Myanmar ranks 43rd and Syrian Arab Republic ranks 45th of 54 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Confirmed cases of MDR-TB started treatment for MDR-TB (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.